Peter C. Minneci

Apr 24, 2024 | jamanetwork.com | David A. Talan |Peter C. Minneci

Offering interval appendectomy to patients who are recovered after antibiotic treatment of acute uncomplicated appendicitis exposes them to additional risk, disability, and cost in an attempt to avoid a future illness they most likely would never experience with a surgery they most likely would never need. As more patients choose nonoperative treatment, there will be increased opportunity for us to consider interval appendectomy after resolution of appendicitis.

Apr 3, 2024 | jamanetwork.com | Peter C. Minneci |Delaware Valley |Lindsey Asti |Katherine Deans

Analysis of the Laser Epilation in Pilonidal Disease Trial—Reply In Reply We appreciate the comments from Mei and colleagues regarding the potential effects of the COVID-19 pandemic and differences in follow-up and compliance on recurrence rates in our trial.1 The COVID-19 pandemic caused a period during which we were unable to perform LE and led to 15 patients in the LE group withdrawing from the study due to COVID-19–related concerns about the risks associated with hospital visits for...

Nov 8, 2023 | jamanetwork.com | Peter C. Minneci |Delaware Valley |Lindsay A. Gil |Jennifer Cooper

Key PointsQuestion  Is laser epilation (LE) as an adjunct to standard care more effective in reducing pilonidal disease recurrence than standard care alone? Findings  In this randomized clinical trial of 302 adolescents and young adults, recurrence rates over 1 year were significantly lower in the LE group vs the standard care group.

Sep 20, 2023 | jamanetwork.com | Lindsay A. Gil |Katherine Deans |Peter C. Minneci

Moving Toward Minimally Invasive Treatments and Better Risk Characterization for Pilonidal Disease—Reply In Reply We thank Garg and Hemrajani as well as Lev-Tov for their interest in our Review and for taking the time to share their thoughts for discussion.

May 31, 2023 | jamanetwork.com | Lindsay A. Gil |Katherine Deans |Delaware Valley |Peter C. Minneci

Abstract Importance  The management of pilonidal disease continues to be a challenge due to high rates of recurrence and treatment-associated morbidity. Observations  There is a heterogeneous repertoire of treatment modalities used in the management of pilonidal disease and wide practice variation among clinicians.